Market Wrap | US Stock Market Plummets Amid Rising Treasury Yields

On May 21, 2025, the U.S. stock market experienced a significant decline, with the S&P 500 Index falling 1.61%, the Dow Jones Industrial Average dropping 1.91%, and the Nasdaq Composite Index decreasing 1.41%. This downturn was largely driven by rising long-term Treasury yields, which increased borrowing costs and dampened investor sentiment. The 10-year U.S. Treasury yield rose by approximately 5 basis points to 4.53%, further exacerbating the market's negative outlook.

The market saw a mixed performance across various sectors, with several key industries underperforming the S&P 500. The Utilities sector, Technology sector, Healthcare sector, Consumer Discretionary sector, Energy sector, Industrials sector, Real Estate sector, and Financials sector all lagged behind the broader market index. This indicates a challenging day for these sectors, which may reflect broader economic concerns or sector-specific issues.

Today, several notable companies experienced significant movements in their stock prices. Palantir Technologies saw a drop of 3.99%, with its high valuation premium posing a risk during potential market corrections. UnitedHealth Group faced a 5.78% decline due to allegations surrounding secret payments to nursing homes. Wells Fargo's stock dropped by 3.09%, impacted by a credit rating downgrade and ongoing legal issues. American Express experienced a 3.43% decrease, as a new phishing scam targets its cardholders, potentially damaging customer trust and security. Bank of America's stock fell by 3.22%, following Moody's downgrade of its deposit ratings due to US credit concerns.

Today, the U.S. stock market saw significant movements across several companies. Lottery.com surged over 131%, while Sigmatron International rose nearly 130% after announcing a strategic partnership to expand its market reach and enhance product offerings. On the downside, Wolfspeed plummeted over 59% as the company is reportedly considering filing for bankruptcy due to mounting debt. Petros Pharmaceuticals dropped nearly 46% following its delisting from Nasdaq, which has affected investor confidence.

请提供新闻列表，以便我为您挑选和总结相关内容。